Kaufmann_2011_J.Pharm.Pharmacol_63_1368

Reference

Title : Myrtenal inhibits acetylcholinesterase, a known Alzheimer target - Kaufmann_2011_J.Pharm.Pharmacol_63_1368
Author(s) : Kaufmann D , Dogra AK , Wink M
Ref : J Pharm Pharmacol , 63 :1368 , 2011
Abstract :

OBJECTIVES: Inhibition of acetylcholinesterase (AChE) is a common treatment for early stages of the most general form of dementia, Alzheimer's disease. In this study selected components of essential oils, which carry a variety of important functional groups, were tested for their in-vitro anti-acetylcholinesterase activity. METHODS: In-vitro anti-acetylcholinesterase activity was measured by an adapted version of Ellman's colorimetric assay. KEY FINDINGS: 1,8-cineole, carvacrol, myrtenal and verbenone apparently inhibited AChE; the highest inhibitory activity was observed for myrtenal (IC50 = 0.17 mm). This is the first study showing the AChE inhibitory activity of myrtenal. CONCLUSIONS: Our investigations provided evidence for the efficacy of monoterpenes as inhibitors of AChE.

PubMedSearch : Kaufmann_2011_J.Pharm.Pharmacol_63_1368
PubMedID: 21899553

Related information

Citations formats

Kaufmann D, Dogra AK, Wink M (2011)
Myrtenal inhibits acetylcholinesterase, a known Alzheimer target
J Pharm Pharmacol 63 :1368

Kaufmann D, Dogra AK, Wink M (2011)
J Pharm Pharmacol 63 :1368